Home Patent Forecast® Sectors Log In   Contact  
How it works Patent Forecast® Sectors Pricing Insights
Enjoy your FREE PREVIEW which shows only 2021 data and 25 documents. For full access, try it free at any time.        

AI Biotech/Diagnostics: Cardio

Read More News and Insights

Cognoa receives FDA Breakthrough Device designations

AI Biotech/Diagnostics: Cardio Patent Forecast®

February 13, 2019

Cognoa announced that its first digital diagnostic and digital therapeutic devices to treat autism have received Breakthrough Device designations from the FDA.
Cognoa, located in Palo Alto CA, is developing methods for evaluating a subject for a developmental condition that can be tuned to control the tradeoff between coverage and reliability. Cognoa is also developing a digital personalized medicine system that uses digital data to assess or diagnose symptoms of a subject to provide personalized therapeutic interventions and improved diagnoses.

Relevant Patent Documents

Application US20190043618  

Application US20190043619  

Application US20190043610  

Article Source Link


Read more like this in News This Week!   or   Share this link with your connections!